Company intelligence / Profile preview

Carlyle Services

Washington, D.C., District of Columbia, United States

Ownership: Private
Employees: ~2300
Development stage: Other

Overview

The Carlyle Group is a global private equity and alternative asset management firm with over $440 billion in assets under management as of 2024. It invests across sectors, including healthcare, life sciences, technology, and others. Recent health-care-related activities include acquisitions of Abingworth (a life science VC firm), investments in clinical research technology firms like Saama, and acquisitions of gene therapy firms such as bluebird bio

Industry: Investors

Partnerships

Amgen VenturesIntermountain VenturesMerck Global Health Innovation FundMcKesson VenturesNorthpond VenturesPfizer VenturesPopulation Health Partners

Beyond the preview

Go deeper on Carlyle Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carlyle Services.

Explore the full profile